Matschiner G, Fitzgerald MF, Moebius U, Hohlbaum AM, et al. Elarekibep (PRS-060/AZD1402): a new class of inhaled Anticalin medicine targeting IL-4Ra for T2 endotype asthma. J Allergy Clin Immunol 2022 Dec 30:S0091-6749(22)02588.
PMID: 36592703